EG vs TERN · P/E 17, rev $17.28B vs $6.12B cap
Everest Group Ltd (EG) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
EG currently screens at market cap $14.52B and trailing P/E 17.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the EG and TERN stock pages for the full models.
Not investment advice.